• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 GLIDEPATH HEMODIALYSIS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 GLIDEPATH HEMODIALYSIS CATHETER Back to Search Results
Catalog Number 6393190
Device Problems Corroded (1131); Material Discolored (1170); Material Opacification (1426); Stretched (1601); Material Deformation (2976); Material Protrusion/Extrusion (2979)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/26/2021
Event Type  malfunction  
Event Description
It was reported that eight months post dialysis catheter placement, the catheter was allegedly noted to be discoloured and corroded.There was no reported patient injury.
 
Manufacturer Narrative
As the lot number for the device was provided, a review of the device history records was performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.(expiration date: 05/2021).
 
Event Description
It was reported that eight months post dialysis catheter placement, the catheter was allegedly noted to be discolored and corroded.It was further reported that the device was removed.There was no reported patient injury.
 
Manufacturer Narrative
H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: one 19cm glidepath d/l catheter was returned for evaluation.Gross visual and functional evaluation.The investigation is confirmed for the identified material opacification and material deformation issues as both the extension legs appeared emulsified and a bulge was noted on the venous extension leg just distal to the bifurcation.Further the catheter was noted to be flattened.However, the investigation is unconfirmed for the reported catheter discoloration and corrosion issues as no objective evidence related to the reported event was noted on the catheter.The definitive root cause could not be determined based upon available information.Labeling review: a review of product labeling documentation (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H10: b5, d4 (expiry date: 05/2021).H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Manufacturer Narrative
Manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: one 19cm glidepath d/l catheter was returned for evaluation.Gross visual and functional evaluation.The investigation is confirmed for the identified material opacification, material deformation and stretched issues as both the extension legs appeared to be in a milky white color and a bulge was noted on the venous extension leg just distal to the bifurcation.However, the investigation is unconfirmed for the reported catheter discoloration and corrosion issues as no objective evidence related to the reported event was noted on the catheter.A definitive root cause could not be determined based upon the available information.Labeling review: a review of product labeling documentation (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.D4 (expiry date: 05/2022).H11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported that approximately eight months post dialysis catheter placement, the catheter was allegedly noted to be discolored and corroded.It was further reported that the device was removed.There was no reported patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GLIDEPATH HEMODIALYSIS CATHETER
Type of Device
DIALYSIS CATHETER
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key13058157
MDR Text Key282605822
Report Number3006260740-2021-05382
Device Sequence Number1
Product Code MSD
UDI-Device Identifier00801741138492
UDI-Public(01)00801741138492
Combination Product (y/n)N
Reporter Country CodeGR
PMA/PMN Number
K051748
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 06/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number6393190
Device Lot NumberREDU2651
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/14/2021
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/26/2021
Initial Date FDA Received12/22/2021
Supplement Dates Manufacturer Received12/27/2021
06/13/2022
Supplement Dates FDA Received12/29/2021
06/13/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/24/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age53 YR
Patient SexFemale
-
-